Oil Prices Jump as US and Iran Signal Truce in Gulf Shipping War
Oil prices rise 3% after US and Iran agree to suspend attacks in the Persian Gulf, but questions remain about IRGC compliance and market stability.
Oil prices rise 3% after US and Iran agree to suspend attacks in the Persian Gulf, but questions remain about IRGC compliance and market stability.
Wimbledon is back, but you don’t need a trust fund to play tennis. Here’s how to start with a $15 racket, free courts, and AI coaching that beats $100 lessons.
Qantas completes 19-hour London-Sydney test flight. Will passengers pay $10,000 for non-stop travel? Inside the science, economics, and future of ultra-long-haul aviation.
Multicoin Capital forecasts HYPE token could hit $319 as Hyperliquid expands beyond perpetual futures into spot, lending, and real-world assets. Analysis inside.
Invesco launches a tokenized money market fund targeting stablecoin reserves, competing with BlackRock’s BUIDL and Franklin Templeton’s BENJI. Details on structure, impact, and risks.
Wendy’s stock surged 87% in a meme stock frenzy, but fundamentals tell a different story. We break down the Reddit-fueled rally, the risks, and what it means for investors.
President Trump threatens 100% tariff on European imports unless EU drops digital services taxes, jeopardizing a trade deal finalized days ago. Markets roil.
King Charles paid £12.9m in tax for 2024-2025 – but it’s voluntary, offset by the Sovereign Grant, and the Duchy of Lancaster dodges corporation tax. Three unusual facts you missed.
President Trump threatens 100% tariffs on European imports over digital services taxes targeting U.S. tech giants. Market impact, consumer costs, and trade war risks analyzed.
Lithium battery fires from power banks and vapes are now the top safety risk on aircraft. Device seizures have doubled in a year. Inside the regulatory battle.
Asia stock markets tumble as tech shares slide on AI spending doubts. South Korea’s Kospi halts trading for the third time this week, triggering circuit breakers. Expert analysis and market impact.
Nature Medicine retracts a high-profile study claiming morning immunotherapy is more effective. Data integrity concerns cited. What this means for cancer patients and chronotherapy research.